Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression

Jan

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.

Feb

Featured Webinar

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

In this session, the second in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review cases in which patient genomic profiles exhibit common driver mutations in tumor types considered “off label” for targeted therapies associated with those mutations.

Menu

Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression

To read the full story....

Breaking News

Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines

Bionano Genomics to Raise $200M in Public Stock Offering

CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

Interpace Bio Q3 Revenues Rise 6 Percent

Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

Predictive Oncology Prices $2.2M Direct Offering

Recent Headlines from
Precision Oncology News

MSK Researchers Chip Away at TMB Unknowns, Clarify Role in Predicting Immunotherapy Benefit

Ariz Precision Medicine Bets on a New Class of Cancer Drugs Targeting PRDM Genes

Precision Oncology in 2020: Pandemic Lessons, Biomarker Controversies, Community Access Gaps

Lynparza Cost-Effectiveness Analysis IDs Pancreatic Cancer Subgroups That Derive Most Benefit

Roche's Ipatasertib Shows No PFS Benefit in Phase III, Biomarker-Guided TNBC Trial

Featured White Papers

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

What's Popular?

CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance

Predictive Oncology Prices $2.2M Direct Offering

OncoHost Raises $8 Million in Series B Funding Round

Sponsorships